Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Cooperative Research Agreements Related to the World Trade Center Health Program (U01) PAR 12-126, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (92), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8:00 a.m.-5:00 p.m., March 5, 2013 (Closed).
Place: CDC, Roybal Campus, Building 19 (Global Communications Center), Rooms 245/246, Atlanta, Georgia 30333, Telephone: (404) 639-4800.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to 92.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Cooperative Research Agreements Related to the World Trade Center Health Program (U01) PAR 12-126.”
Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G800, Morgantown, West Virginia 26505, Telephone: (304) 285-5976.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013-01978 Filed 1-29-13; 8:45 am]
BILLING CODE 4163-18-P